Works matching IS 19466234 AND DT 2021 AND VI 13 AND IP 607

Results: 6

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models.
Published in:
Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abh0755
By:
- van Doremalen, Neeltje;
- Purushotham, Jyothi N.;
- Schulz, Jonathan E.;
- Holbrook, Myndi G.;
- Bushmaker, Trenton;
- Carmody, Aaron;
- Port, Julia R.;
- Yinda, Claude K.;
- Okumura, Atsushi;
- Saturday, Greg;
- Amanat, Fatima;
- Krammer, Florian;
- Hanley, Patrick W.;
- Smith, Brian J.;
- Lovaglio, Jamie;
- Anzick, Sarah L.;
- Barbian, Kent;
- Martens, Craig;
- Gilbert, Sarah C.;
- Lambe, Teresa
Publication type:
Article
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.
Published in:
Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abi4547
By:
- Francica, Joseph R.;
- Flynn, Barbara J.;
- Foulds, Kathryn E.;
- Noe, Amy T.;
- Werner, Anne P.;
- Moore, Ian N.;
- Gagne, Matthew;
- Johnston, Timothy S.;
- Tucker, Courtney;
- Davis, Rachel L.;
- Flach, Britta;
- O'Connell, Sarah;
- Andrew, Shayne F.;
- Lamb, Evan;
- Flebbe, Dillon R.;
- Nurmukhambetova, Saule T.;
- Donaldson, Mitzi M.;
- Todd, John-Paul M.;
- Zhu, Alex Lee;
- Atyeo, Caroline
Publication type:
Article
Blocking α4β7 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies.
Published in:
Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abf7201
By:
- Frank, Ines;
- Cigoli, Mariasole;
- Arif, Muhammad S.;
- Fahlberg, Marissa D.;
- Maldonado, Stephanie;
- Calenda, Giulia;
- Pegu, Amarendra;
- Yang, Eun Sung;
- Rawi, Reda;
- Chuang, Gwo-Yu;
- Geng, Hui;
- Liu, Cuiping;
- Zhou, Tongqing;
- Kwong, Peter D.;
- Arthos, James;
- Cicala, Claudia;
- Grasperge, Brooke F.;
- Blanchard, James L.;
- Gettie, Agegnehu;
- Fennessey, Christine M.
Publication type:
Article
Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia.
Published in:
Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abe1633
By:
- Villa, Chiara;
- Legato, Mariella;
- Umbach, Alessandro;
- Riganti, Chiara;
- Jones, Rebecca;
- Martini, Beatrice;
- Boido, Marina;
- Medana, Claudio;
- Facchinetti, Irene;
- Barni, Dario;
- Pinto, Milena;
- Arguello, Tania;
- Belicchi, Marzia;
- Fagiolari, Gigliola;
- Liaci, Carla;
- Moggio, Maurizio;
- Ruffo, Riccardo;
- Moraes, Carlos T.;
- Monguzzi, Angelo;
- Merlo, Giorgio R.
Publication type:
Article
ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156.
Published in:
Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abd5750
By:
- Koneru, Balakrishna;
- Farooqi, Ahsan;
- Nguyen, Thinh H.;
- Chen, Wan Hsi;
- Hindle, Ashly;
- Eslinger, Cody;
- Makena, Monish Ram;
- Burrow, Trevor A.;
- Wilson, Joanne;
- Smith, Aaron;
- Pilla Reddy, Venkatesh;
- Cadogan, Elaine;
- Durant, Stephen T.;
- Reynolds, C. Patrick
Publication type:
Article
The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia.
Published in:
Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abd3904
By:
- Caffall, Zachary F.;
- Wilkes, Bradley J.;
- Hernández-Martinez, Ricardo;
- Rittiner, Joseph E.;
- Fox, Jennifer T.;
- Wan, Kanny K.;
- Shipman, Miranda K.;
- Titus, Steven A.;
- Zhang, Ya-Qin;
- Patnaik, Samarjit;
- Hall, Matthew D.;
- Boxer, Matthew B.;
- Shen, Min;
- Li, Zhuyin;
- Vaillancourt, David E.;
- Calakos, Nicole
Publication type:
Article

Works matching IS 19466234 AND DT 2021 AND VI 13 AND IP 607

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models.

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.

Blocking α<sub>4</sub>β<sub>7</sub> integrin delays viral rebound in SHIV<sub>SF162P3</sub>-infected macaques treated with anti-HIV broadly neutralizing antibodies.

Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia.

ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156.

The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia.